Consort Medical plc (CSRT.L) (CSRT) Share Price, News & Analysis

Company Overview

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is headquartered in Hemel Hempstead, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 1,010 to 1,010
• 52-Week Range: N/A
• Volume: 768 shs
• Average Volume: 520,697 shs
• Market Capitalization: £504.60 million
• P/E Ratio: 127.85
• Dividend Yield: 2.75%
• Price Target: N/A
• Consensus Rating: N/A

CSRT Stock Analysis - Frequently Asked Questions

How do I buy shares of Consort Medical plc (CSRT.L)?

Shares of CSRT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Consort Medical plc (CSRT.L) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Consort Medical plc (CSRT.L) investors own include Chubb (CB), Newcrest Mining (NCM), Petrel Resources (PET), Atco Mining (ATMGF), Barrick Gold (ABX), Bank of Ireland Group (BKRIY) and Colony Capital (CLNY).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Appliances & Equipment
• Sub-Industry: N/A
• Current Symbol: LON:CSRT
• CUSIP: N/A
• CIK: N/A
• Web: www.consortmedical.com
• Phone: +44-1442-867920
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 127.85
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 55.58
• Current Ratio: 1.83
• Quick Ratio: 1.16

Sales & Book Value

• Annual Sales: £298.60 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 33.44
• Book Value: GBX 465.50 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 49,960,600
• Free Float: N/A
• Market Cap: £504.60 million
• Optionable: Not Optionable
• Beta: N/A